Teriparatide: Label changes and identifying patients for long-term use

Cleve Clin J Med. 2021 Sep 1;88(9):489-493. doi: 10.3949/ccjm.88a.21011.
No abstract available

MeSH terms

  • Bone Density
  • Bone Density Conservation Agents* / adverse effects
  • Humans
  • Osteoporosis* / drug therapy
  • Teriparatide

Substances

  • Bone Density Conservation Agents
  • Teriparatide